Autolus’ Aucatzyl is a B-lymphocyte antigen CD19 CAR-T cell therapy. Credit: NDAB Creativity via Shutterstock. Autolus ...

Watch out, Gilead and Novartis: there's a new CAR-T in town. Autolus is ready to hit the ground running after winning FDA approval for its Aucatzyl, a late entry to the heated CD19 CAR-T cell therapy ...

Investors interested in Business Services stocks should always be looking to find the best-performing companies in the group. AppLovin (APP) is a stock that can certainly grab the attention of many ...

GSK’s departure comes as the industry anticipates the incoming Trump administration and as it continues to grapple with the threat of the BIOSECURE Act and losses of legal challenges to the IRA’s drug ...

Nigeria, the giant of Africa, has recently experienced a great downturn in its economy, leading to the exodus of several ...

Astrazeneca is set to report earnings next week after a turbulant few months for the FTSE 100 firm and its China arm.

In the coming truncated week, the markets are expected to consolidate further with stock-specific action due to global ...

IonQ has shown remarkable stock performance despite being labeled "risky" and "unproven". Find out why I'm bullish on IONQ ...

However, in a twist last October, Emmerdale producers decided to write out Amelia, a move that left Daisy, aged 21, reeling ...

As Nigeria struggles over the high cost of essential drugs, Seagreen Pharmaceuticals has officially reintroduced the amino ...

The Sri Lanka–Indonesia Business Council (SLIBC) of The Ceylon Chamber of Commerce conducted a Business Promotion Mission to ...

AstraZeneca’s presence in South Africa has become a driving force in global health research, contributing significantly to respiratory, cardiovascular, and oncology therapeutic areas. The ...